Enrik Enchev-Hristov, Mariona Esteve-Serra, Luz M-R Céspedes, Rebeca Barahona-San Millán, Mònica Recasens-Sala, Lidia Sojo-Vega, Elisabet Costa-Lima, José Manuel-Fernández Real, Wifredo Ricart-Engel, Mercè Fernández-Balsells
AIM: In a world of data overload, clinical practice recommendations are needed to help practitioners and patients to take evidence-based decisions. However, in the field of type 2 diabetes mellitus (T2DM) recommendations on glycemic goals and treatment choice are controversial in spite of being supported by a common body of evidence. We hypothesize that internal and external validity of this body of evidence might not be as sound as expected. The aim of the current study is to appraise the studies supporting recommendations developed by influential medical societies dealing with glycemic goals and the choice of pharmacological treatment in adults with T2DM...
July 17, 2020: International Journal of Evidence-based Healthcare